Kura Oncology (KURA) Gets a Buy from Jefferies
In a report released today, Roger Song from Jefferies maintained a Buy rating on Kura Oncology (KURA – Research Report), with a price target of ...
Kura Oncology: Sentiment Is Too Negative
Kura Oncology's stock plummeted 50% after announcing a collaboration with Kyowa Kirin, making it a less attractive ...
ETF Daily News7 天
Cantor Fitzgerald Forecasts Kura Oncology FY2025 Earnings
an orally bioavailable farnesyl transferase inhibitor combination with alpelisib for patients with PIK3CA-dependent HNSCC; and KO-2806, a farnesyl transferase inhibitor for the treatment of solid ...
ETF Daily News15 天
Kura Oncology Signs Lease Agreement for New Executive Offices
an orally bioavailable farnesyl transferase inhibitor combination with alpelisib for patients with PIK3CA-dependent HNSCC; and KO-2806, a farnesyl transferase inhibitor for the treatment of solid ...
Nature7 天
Farnesyl Diphosphate Synthase Inhibitors And Mevalonate Pathway Research
Farnesyl diphosphate synthase (FPPS) is a key enzyme in this pathway, and its inhibitors have garnered significant attention for their potential therapeutic applications, particularly in cancer ...
Medscape3 天
Therapeutic Potential of Statins in Thyroid Proliferative Disease
Expression and/or activity of HMG-CoA reductase, farnesyl transferase and geranylgeranyl transferase have been associated with cell proliferation, and aberrant expression of these enzymes seems to ...